Vivoryon Therapeutics Market Cap

Vivoryon Therapeutics has a market cap or net worth of 36.89 million as of February 12, 2026. Its market cap has decreased by -12.91% in one year.

Market Cap

36.89M

Enterprise Value

32.74M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

1.41

Market Cap Chart

Since October 27, 2014, Vivoryon Therapeutics's market cap has decreased from 106.65M to 36.89M, a decrease of -65.41%. That is a compound annual growth rate of -8.97%.

Market Cap History

Date	Market Cap	% Change
Feb 11, 2026	37.34M	1.79%
Dec 31, 2025	36.69M	-14.48%
Dec 31, 2024	42.90M	-76.70%
Dec 29, 2023	184.13M	-16.55%
Dec 30, 2022	220.65M	-30.94%
Dec 31, 2021	319.49M	98.13%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AstraZeneca	229.82B
GSK plc	86.28B
Haleon	36.19B
Smith & Nephew	10.90B
Kooth	46.30M
AOTI, Inc.	44.67M
Ondine Biomedical	41.09M
Provexis	35.19M

Market Cap Rankings